Fluorescence Based on Surface Plasmon Coupled Emission for Ultrahigh Sensitivity Immunoassay of Cardiac Troponin I

This work demonstrates the quantitative assay of cardiac Troponin I (cTnI), one of the key biomarkers for acute cardiovascular diseases (the leading cause of death worldwide) using the fluorescence-based sandwich immune reaction. Surface plasmon coupled emission (SPCE) produced by non-radiative coup...

Full description

Bibliographic Details
Main Authors: Vien Thi Tran, Heongkyu Ju
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/9/5/448
_version_ 1797536828359704576
author Vien Thi Tran
Heongkyu Ju
author_facet Vien Thi Tran
Heongkyu Ju
author_sort Vien Thi Tran
collection DOAJ
description This work demonstrates the quantitative assay of cardiac Troponin I (cTnI), one of the key biomarkers for acute cardiovascular diseases (the leading cause of death worldwide) using the fluorescence-based sandwich immune reaction. Surface plasmon coupled emission (SPCE) produced by non-radiative coupling of dye molecules with surface plasmons being excitable via the reverse Kretschmann format is exploited for fluorescence-based sandwich immunoassay for quantitative detection of cTnI. The SPCE fluorescence chip utilizes the gold (2 nm)-silver (50 nm) bimetallic thin film, with which molecules of the dye Alexa 488 (conjugated with detection antibodies) make a near field coupling with the plasmonic film for SPCE. The experimental results find that the SPCE greatly improves the sensitivity via enhancing the fluorescence signal (up to 50-fold) while suppressing the photo-bleaching, permitting markedly enhanced signal-to-noise ratio. The limit of detection of 21.2 ag mL<sup>−1</sup> (atto-gram mL<sup>−1</sup>) is obtained, the lowest ever reported to date amid those achieved by optical technologies such as luminescence and label-free optical sensing techniques. The features discovered such as ultrahigh sensitivity may prompt the presented technologies to be applied for early diagnosis of cTnI in blood, particularly for emergency medical centers overloaded with patients with acute myocardial infarction who would suffer from time-delayed diagnosis due to insufficient assay device sensitivity.
first_indexed 2024-03-10T12:07:19Z
format Article
id doaj.art-12761345eb5642d18ea8a58fe5648660
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T12:07:19Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-12761345eb5642d18ea8a58fe56486602023-11-21T16:29:43ZengMDPI AGBiomedicines2227-90592021-04-019544810.3390/biomedicines9050448Fluorescence Based on Surface Plasmon Coupled Emission for Ultrahigh Sensitivity Immunoassay of Cardiac Troponin IVien Thi Tran0Heongkyu Ju1Department of Physics, Gachon University, Seongnam-si, Gyeonggi-do 13120, KoreaDepartment of Physics, Gachon University, Seongnam-si, Gyeonggi-do 13120, KoreaThis work demonstrates the quantitative assay of cardiac Troponin I (cTnI), one of the key biomarkers for acute cardiovascular diseases (the leading cause of death worldwide) using the fluorescence-based sandwich immune reaction. Surface plasmon coupled emission (SPCE) produced by non-radiative coupling of dye molecules with surface plasmons being excitable via the reverse Kretschmann format is exploited for fluorescence-based sandwich immunoassay for quantitative detection of cTnI. The SPCE fluorescence chip utilizes the gold (2 nm)-silver (50 nm) bimetallic thin film, with which molecules of the dye Alexa 488 (conjugated with detection antibodies) make a near field coupling with the plasmonic film for SPCE. The experimental results find that the SPCE greatly improves the sensitivity via enhancing the fluorescence signal (up to 50-fold) while suppressing the photo-bleaching, permitting markedly enhanced signal-to-noise ratio. The limit of detection of 21.2 ag mL<sup>−1</sup> (atto-gram mL<sup>−1</sup>) is obtained, the lowest ever reported to date amid those achieved by optical technologies such as luminescence and label-free optical sensing techniques. The features discovered such as ultrahigh sensitivity may prompt the presented technologies to be applied for early diagnosis of cTnI in blood, particularly for emergency medical centers overloaded with patients with acute myocardial infarction who would suffer from time-delayed diagnosis due to insufficient assay device sensitivity.https://www.mdpi.com/2227-9059/9/5/448fluorescencecardiac biomarkerTroponin Isurface plasmon coupled emissionlab-on-chip optical biosensor
spellingShingle Vien Thi Tran
Heongkyu Ju
Fluorescence Based on Surface Plasmon Coupled Emission for Ultrahigh Sensitivity Immunoassay of Cardiac Troponin I
Biomedicines
fluorescence
cardiac biomarker
Troponin I
surface plasmon coupled emission
lab-on-chip optical biosensor
title Fluorescence Based on Surface Plasmon Coupled Emission for Ultrahigh Sensitivity Immunoassay of Cardiac Troponin I
title_full Fluorescence Based on Surface Plasmon Coupled Emission for Ultrahigh Sensitivity Immunoassay of Cardiac Troponin I
title_fullStr Fluorescence Based on Surface Plasmon Coupled Emission for Ultrahigh Sensitivity Immunoassay of Cardiac Troponin I
title_full_unstemmed Fluorescence Based on Surface Plasmon Coupled Emission for Ultrahigh Sensitivity Immunoassay of Cardiac Troponin I
title_short Fluorescence Based on Surface Plasmon Coupled Emission for Ultrahigh Sensitivity Immunoassay of Cardiac Troponin I
title_sort fluorescence based on surface plasmon coupled emission for ultrahigh sensitivity immunoassay of cardiac troponin i
topic fluorescence
cardiac biomarker
Troponin I
surface plasmon coupled emission
lab-on-chip optical biosensor
url https://www.mdpi.com/2227-9059/9/5/448
work_keys_str_mv AT vienthitran fluorescencebasedonsurfaceplasmoncoupledemissionforultrahighsensitivityimmunoassayofcardiactroponini
AT heongkyuju fluorescencebasedonsurfaceplasmoncoupledemissionforultrahighsensitivityimmunoassayofcardiactroponini